New Issue: Navigating Conflicting Vaccination Recommendations; Plus New Issue: PCSK9 Enlicitide & Heterozygous FH, MASLD Review, and 2025 Research of the Year

Back to news list

Source: Email Newsletter

Original: email://575...

Published: Tue, 13 Jan 2026 15:23:56 -0600 (CST)

Brief, factual summary in Slovak: The new issue of JAMA contains several important topics. The first is navigation contrary to vaccination recommendations. Additional topics include the efficacy and safety of the oral PCSK9 inhibitor enlicitide in adults with heterozygous familial hypercholesterolemia, as well as a review of metabolic liver damage associated with steatosis in adults. In addition, it also deals with the impact of climate change on allergic rhinitis and sinusitis. The journal provides physicians worldwide with essential medical information and a unique forum for discussions that shape the future of medical practice and public health.